Application of tumor markers in clinical medicine

Abstract

Abstract:Detection of serum tumor markers in clinical application is simple, which has become an indispensable means in clinical medical work，and played an important role in the early detection of malignant tumor, benign and malignant tumor differential diagnosis， guiding the stage and predicting prognosis. But because of its sensitivity and specificity have limitations, we should find more new markers.

Key words:Neoplasms,Clinical medicine,Tumor markers,biological

Cite this article

LI Yu-Quan, WANG Xiu, JIN Gang, WANG Chun. Application of tumor markers in clinical medicine[J]. Journal of International Oncology, 2014, 41(10): 744-746.

share this article

/Recommend

Add to citation managerEndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL:https://gjzlx.sdfmu.edu.cn/EN/10.3760/cma.j.issn.1673422X.2014.10.008

https://gjzlx.sdfmu.edu.cn/EN/Y2014/V41/I10/744

References

［４］张立，黄静，朱晓莉，等．分子标志物指导化疗药物选择的策略在晚期非小细胞肺癌化疗中的有效性及安全性评价［Ｊ］．中国癌症杂志，２０１１，２１（１０）：７９４７９８．［５］吕东晓．血清肿瘤标志物预测同步放化疗对食管鳞癌有效性作用的研究［Ｄ］．济南：济南大学，２０１２．［６］乔蕾，孙玉凤．ＣＥＡ等肿瘤标志物在消化道恶性肿瘤患者转归中漂移的研究［Ｊ］．卫生职业教育，２００７，１３（２５）：１３８１４１．［７］杨娟，张琳，文小霞，等．大肠癌患者血清ＣＥＡ和ＣＡ１９９表达与临床病理因素相关性的回顾性分析［Ｊ］．中华肿瘤防治杂志，２０１２，１５（１９）：７９７９［８］李岩．胃癌肿瘤标志物及临床意义［Ｊ］．实用医院临床杂志，２０１１，１（８）：１１１５．［１０］聂庆东，李艳君，张秀梅．血清肿瘤标记物及ＨＳＰ６０联合检测对大肠癌诊断的意义［Ｊ］．中国实验诊断学，２０１２，１６（１）：５２ ５４．［１１］梁金花，郑科文，鞠传余．胃癌肿瘤标志物临床意义与检测方法的研究现状及展望［Ｊ］．微量元素与健康研究，２０１３，１（３０）：６８７１．［１２］何承志，郜恒骏．胰腺癌相关肿瘤标志物的研究现状［Ｊ］．国际消化病杂志，２０１３，１（３３）：３９４２．

Related Articles15

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Metrics

Viewed

Full text

Abstract

Comments

Abstract
References
Related Articles
Recommended Articles
Metrics
Comments

TOP